Mayo Clinic Arizona, Department of Emergency Medicine, Phoenix, Arizona.
Mayo Clinic Arizona, Department of Radiology, Phoenix, Arizona.
West J Emerg Med. 2024 May;25(3):342-344. doi: 10.5811/westjem.18515.
During the coronavirus 2019 pandemic, hospitals in the United States experienced a shortage of contrast agent, much of which is manufactured in China. As a result, there was a significantly decreased amount of intravenous (IV) contrast available. We sought to determine the effect of restricting the use of IV contrast on emergency department (ED) length of stay (LOS).
We conducted a single-institution, retrospective cohort study on adult patients presenting with abdominal pain to the ED from March 7-July 5, 2022. Of 26,122 patient encounters reviewed, 3,028 (11.6%) included abdominopelvic CT with a complaint including "abdominal pain." We excluded patients with outside imaging and non-ED scans. Routine IV contrast agent was administered to approximately 74.6% of patients between March 7-May 6, 2022, when we altered usage guidelines due to a nationwide shortage. Between May 6-July 5, 2022, 32.8% of patients received IV contrast after institutional recommendations were made to limit contrast use. We compared patient demographics and clinical characteristics between groups with chi-square test for frequency data. We analyzed ED LOS with nonparametric Wilcoxon rank-sum test for continuous measures with focus before and after new ED protocols. We also used statistical process control charts and plotted the 1, 2 and 3 sigma control limits to visualize the variation in ED LOS over time. The charts include the average (mean) of the data and upper and lower control limits, corresponding to the number of standard deviations away from the mean.
After use of routine IV contrast was discontinued, ED LOS (229.0 vs 212.5 minutes, = <0.001) declined by 16.5 minutes (95% confidence interval -10, -22).
Intravenous contrast adds significantly to ED LOS. Decreased use of routine IV contrast in the ED accelerates time to CT completion. A policy change to limit IV contrast during a national shortage significantly decreased ED LOS.
在 2019 年冠状病毒病大流行期间,美国的医院经历了造影剂短缺,其中大部分造影剂是中国制造的。结果,静脉(IV)造影剂的供应量显著减少。我们试图确定限制 IV 造影剂使用对急诊部(ED)停留时间(LOS)的影响。
我们对 2022 年 3 月 7 日至 7 月 5 日期间因腹痛到 ED 就诊的成年患者进行了一项单机构、回顾性队列研究。在审查的 26122 例患者中,3028 例(11.6%)包括腹部和骨盆 CT,其主诉包括“腹痛”。我们排除了有外部影像学和非 ED 扫描的患者。在 2022 年 3 月 7 日至 5 月 6 日期间,大约 74.6%的患者接受了常规 IV 造影剂,此时由于全国范围内的短缺,我们改变了使用指南。在 2022 年 5 月 6 日至 7 月 5 日期间,在机构建议限制造影剂使用后,32.8%的患者接受了 IV 造影剂。我们使用卡方检验比较了两组患者的人口统计学和临床特征,对于连续变量使用非参数 Wilcoxon 秩和检验。我们使用统计过程控制图绘制了 1、2 和 3 西格玛控制限,以直观地观察 ED LOS 随时间的变化。图表包括数据的平均值(均值)和上下控制限,对应于与均值相差的标准差数。
常规 IV 造影剂停用后,ED LOS(229.0 与 212.5 分钟, = <0.001)减少了 16.5 分钟(95%置信区间 -10,-22)。
静脉造影剂显著增加 ED LOS。ED 中常规 IV 造影剂的使用减少可加速 CT 完成时间。在全国短缺期间限制 IV 造影剂的政策变化显著缩短了 ED LOS。